OTHER · Unmapped registry intervention
Meal Test
Find medicine records ·
Find other trials using this name
Clinical trial
Immune Biomarkers of Residual Beta-cell Mass in Type 1 Diabetes
NCT01747967
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedImmune Biomarkers of Residual Beta-cell Mass in Type 1 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Meal TestOTHER
Sponsors & collaborators
Assistance Publique - Hôpitaux de Parislead sponsor
URC-CIC Paris Descartes Necker Cochincollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01747967 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.